CORBF — Global Cord Blood Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareSpeculativeSmall Cap
- $167.39m
- -$751.84m
- CNY1.24bn
Annual cashflow statement for Global Cord Blood, fiscal year end - March 31st, CNY millions except per share, conversion factor applied.
2018 March 31st | 2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 20-F | 20-F | 20-F | 20-F | 20-F |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 241 | 295 | 478 | 516 | 509 |
| Depreciation | |||||
| Amortisation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 117 | 95.8 | 40 | 14.2 | 56.7 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 420 | 363 | 64.1 | 58.3 | -3.77 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Taxes Payable | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | 819 | 792 | 624 | 631 | 614 |
| Capital Expenditures | -67.1 | -30.7 | -24.2 | -20.9 | -19.8 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0.589 | 0.479 | -122 | 0.785 | 0.154 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | -66.5 | -30.2 | -146 | -20.1 | -19.6 |
| Financing Cash Flow Items | -2.02 | -3.02 | -4.04 | -6.07 | -7.73 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -2.02 | -21.2 | -4.04 | -6.07 | -7.73 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 740 | 747 | 476 | 602 | 585 |